BP000458-SARS-250: Recombinant SARS-CoV Nucleocapsid (422a.a)
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.
Applications: WB.BP000458-SARS-251: Recombinant SARS-Associated Coronavirus Matrix
Source: E. coli-derived.
Specificity: SARS Matrix protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.BP000458-SARS-252: Recombinant SARS-Associated Coronavirus Envelope
Source: E. coli-derived.
Specificity: SARS Envelope protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE(coomassie staining).
Applications: WB, ELISA.BP000458-SARS-253: Recombinant SARS-Associated Coronavirus Nucleocapsid Core
Source: E. coli-derived.
Specificity: SARS Core protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.BP000458-SARS-254: Recombinant SARS-Associated Coronavirus Nucleocapsid Core (340-390 a.a.)
Source: E. coli-derived.
Specificity: SARS Core protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.BP000458-SARS-255: Recombinant SARS-Associated Coronavirus Nucleocapsid Core (1-49,192-220 a.a.)
Source: E. coli-derived.
Specificity: SARS Core protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.BP000458-SARS-256: Recombinant SARS-Associated Coronavirus Spike Mosaic S (M)
Source: E. coli-derived.
Specificity: Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (Coomassie staining).
Applications: WB, ELISA.BP000458-SARS-257: Recombinant SARS-Associated Coronavirus Spike Mosaic S(C)
Source: E. coli-derived.
Specifcity: SARS Mosaic protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.BP000458-SARS-258: Recombinant SARS-Associated Coronavirus Spike Mosaic S (N)
Source: E. coli-derived.
Specificity: SARS Mosaic protein is Immunoreactive with sera of SARS-infected individuals.
Purity > 95%, by 10% PAGE (coomassie staining).
Applications: WB, ELISA.